Stereotactic body radiotherapy for early-stage non-small cell lung cancer: a multicentre study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Samper Ots PM
  • Vallejo Ocana, C.
  • Martin Martin M
  • Farga Albiol D
  • Almendros Blanco P
  • Hernandez Machancoses A
  • Rico Oses M
  • Flamarique Andueza S
  • Romero Ruperto F
  • Maria Bueno C
  • Amaya Escobar E
  • Guerrero Gómez LL
  • Counago, F.
  • Del Pino Alcántara M
  • Ruiz Villar MJ
  • Monroy Antón JL
  • Saez Bueno P
  • Luna Tirado J
  • Del Mar Puertas M
  • Bobo A
  • Diaz de Cerio Martínez I
  • Gascon Costoso N
  • Ferrer Albiach C

Grupos

Abstract

Stereotactic body radiotherapy (SBRT) has become the standard of care for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC) and for patients who refuse surgery. The aim of this study was to evaluate the effectiveness and safety of primary SBRT in patients with early-stage NSCLC.

© 2021. Federación de Sociedades Españolas de Oncología (FESEO).

Datos de la publicación

ISSN/ISSNe:
1699-048X, 1699-3055

Clinical & Translational Oncology  SPRINGER INT PUBL AG

Tipo:
Article
Páginas:
342-349
PubMed:
34487307
Factor de Impacto:
0,764 SCImago
Cuartil:
Q2 SCImago

Citas Recibidas en Web of Science: 6

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Lung cancer, Prognostic factors, SBRT

Campos de Estudio

Cita

Compartir